Home LiteratureArticle Details
PMID: 2155177 Published · ppublish English Journal Article

Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.

Immunology ·Vol. 69 ·No. 2 ·1990-02-00 ·Pages 171-6

Francis MJ, Hastings GZ, Clarke BE, Brown AL, Beddell CR, Rowlands DJ, Brown F

Abstract

Uncoupled peptides from all seven serotypes of foot-and-mouth disease virus (FMDV) protein VP1 have been used to elicit neutralizing antibody responses in guinea-pigs. The responses were largely serotype specific, although some significant cross-neutralization was observed. Dimeric tandem peptides have also been used to simultaneously elicit neutralizing antibodies to two different FMDV serotypes. The possible existence of structural features common to the B-cell neutralization sites or the guinea-pig helper T-cell sites within all seven peptides are analysed and discussed.

MeSH Terms
Amino Acid Sequence Animals Antibodies, Viral/biosynthesis Antibody Specificity Aphthovirus/classification,immunology Female Guinea Pigs Molecular Sequence Data Peptides/immunology Serotyping Viral Structural Proteins/immunology
Chemicals
Antibodies, Viral Peptides Viral Structural Proteins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Francis M J
Department of Virology, Wellcome Biotechnology Ltd, Beckenham, Kent, U.K.
Hastings G Z
Clarke B E
Brown A L
Beddell C R
Rowlands D J
Brown F
References (25)
25 references, click to expand
  1. Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination.
    Br J Exp Pathol. 1976 Apr;57(2):243-7 PMID: 178338
  2. Serological prospects for peptide vaccines against foot-and-mouth disease virus.
    J Gen Virol. 1989 Nov;70 ( Pt 11):2919-30 PMID: 2479714
  3. Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus.
    Nucleic Acids Res. 1981 Apr 24;9(8):1919-31 PMID: 6264400
  4. Antibody response in pig nasal fluid and serum following foot-and-mouth disease infection or vaccination.
    J Hyg (Lond). 1983 Oct;91(2):329-34 PMID: 6315814
  5. Chemical basis of antigenic variation in foot-and-mouth disease virus.
    Nature. 1983 Dec 15-21;306(5944):694-7 PMID: 6318114
  6. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.
    EMBO J. 1982;1(7):869-74 PMID: 6203738
  7. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
    Proc Natl Acad Sci U S A. 1985 Aug;82(15):5131-5 PMID: 2410914
  8. T-cell antigenic sites tend to be amphipathic structures.
    Proc Natl Acad Sci U S A. 1985 Oct;82(20):7048-52 PMID: 2413457
  9. Immunological priming with synthetic peptides of foot-and-mouth disease virus.
    J Gen Virol. 1985 Nov;66 ( Pt 11):2347-54 PMID: 2997370
  10. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    J Gen Virol. 1987 Feb;68 ( Pt 2):305-14 PMID: 2434606
  11. Synthetic peptide vaccines against foot-and-mouth disease. I. Duration of the immune response and priming in guinea-pigs, rabbits and mice.
    J Biol Stand. 1987 Jan;15(1):39-51 PMID: 3031077
  12. Prediction of immunodominant helper T cell antigenic sites from the primary sequence.
    J Immunol. 1987 Apr 1;138(7):2213-29 PMID: 2435793
  13. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants.
    Nature. 1987 Nov 12-18;330(6144):168-70 PMID: 2444892
  14. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
    Nature. 1987 Nov 26-Dec 2;330(6146):381-4 PMID: 2446137
  15. Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals.
    J Gen Virol. 1987 Dec;68 ( Pt 12):3137-43 PMID: 2447225
  16. Analysis of neutralizing epitopes on foot-and-mouth disease virus.
    J Virol. 1988 Jun;62(6):2033-40 PMID: 2835507
  17. Antigenic sites on foot-and-mouth disease virus type A10.
    J Virol. 1988 Aug;62(8):2782-9 PMID: 2455819
  18. Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides.
    J Gen Virol. 1988 Oct;69 ( Pt 10):2483-91 PMID: 2844964
  19. Orientation of epitopes influences the immunogenicity of synthetic peptide dimers.
    Eur J Immunol. 1988 Dec;18(12):2015-9 PMID: 2464496
  20. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.
    Nature. 1989 Feb 23;337(6209):709-16 PMID: 2537470
  21. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    J Gen Virol. 1989 Jan;70 ( Pt 1):59-68 PMID: 2471783
  22. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
    J Gen Virol. 1989 Mar;70 ( Pt 3):625-37 PMID: 2543752
  23. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    J Gen Virol. 1989 Jun;70 ( Pt 6):1493-503 PMID: 2471812
  24. Synthetic T and B cell recognition sites: implications for vaccine development.
    Adv Immunol. 1989;45:195-282 PMID: 2665439
  25. Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains.
    J Hyg (Lond). 1978 Aug;81(1):107-23 PMID: 211160
Article Info
Journal
Immunology
Abbr.
Immunology
ISSN
0019-2805
Published
1990-02-00
Pages
171-6
Language
English
Region
England
NLM ID
0374672
PMCID
PMC1385585
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]